secwatch.observer — SEC 8-K summary
======================================

Issuer:     DarioHealth Corp. (DRIO)
CIK:        0001533998
Form:       8-K
Filed at:   2023-07-24T23:59:59+00:00
Accession:  0001104659-23-083237
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DarioHealth reports preliminary Q2 revenue $6.0-6.15M, new health plan contract for 160K hypertension members
--------------------------------------------------------------------------------

- Preliminary Q2 2023 revenue $6.0-6.15M, driven by B2B channel growth for 10th consecutive quarter.
- Preliminary six-month revenue $13-13.15M; cash and equivalents $52.6M as of June 30, 2023.
- New agreement with large regional health plan to provide hypertension digital solution to over 160,000 members, launching July 2023.
- Strategic partnerships with MedOne (attributed to Sanofi) and Plan (attributed to Solera) expected to contribute to 2023 revenue.
- Private-labeled Aetna platform delivered on schedule; member enrollment expected in 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533998/000110465923083237/0001104659-23-083237-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533998/000110465923083237/tm2321687d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-083237

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer